Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Rs 14,000 a month—for weight loss.But, but, but… India’s obesity problem is no small fry, and Big Pharma is racing to cash in ...

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.

February was heart months, and this is another column in a series about the major risk factors for heart attacks. According ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss the importance of how monitoring your blood sugar levels regularly is important for managing diabetes and how new research shows that ...

Life & Health Network has produced Diabetes Undone, a research-tested intervention in reversing Type 2 diabetes and other ...

The class will include a delicious meal along with real-life applications to help participants make healthier choices for ...

From heart attacks to lung conditions, discover when chest pain demands immediate attention and the key differences between ...